Fuse Science, Inc. Breaks Code on Patchless Insulin Delivery with Simple Roll-On

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
Fuse Science, Inc. (OTCQB: DROP), (www.fusescience.com) an innovative company that possesses proprietary delivery technology set to redefine how consumers receive energy, medicines, vitamins and minerals, today provides further details on their most recent research results. The study results present what the Company believes to be several scientific firsts in transdermal delivery through the epidermis. The Company possesses proprietary patchless delivery technology, which Fuse now knows with certainty that can deliver a wide range of compounds through the epidermis in a simple roll-on application.

The study tested a wide canvass of compounds, with varying physiochemical characteristics, to document the range of compounds that can be encapsulated in the Company's proprietary delivery technology. Success in each area opens the door to a host of product categories that can be significantly improved through utilization of the Company's proprietary technology. The molecular structure of the test cells in the study ranged from small, water soluble and rigid molecules to large, greasy and flexible molecules with a representative sample from over 80% of common compound structures. The Test Cells were as follows: Caffeine, Nicotinic Acid, Folic Acid, Tocopherol Acetate, Polyethylene Glycol, Estradiol, Paclitaxel, and Insulin.

http://www.sacbee.com/2012/10/22/4929144/fuse-science-inc-breaks-code-on.html

Wow! 😱 It's probably 'only 10 years away' 😉
 
Status
Not open for further replies.
Back
Top